Last September, Makan Delrahim, the Assistant Attorney General for the Antitrust Division of the Department of Justice (“DOJ”), announced efforts to streamline antitrust merger reviews with a stated goal of completing the process within six months from the time an investigation begins. According to Mr. Delrahim, the process would benefit from, among other things, (i) earlier engagement with transacting parties, (ii) faster and earlier production of relevant documents, (iii) modifications to timing agreements, and (iv) the elimination of what Mr. Delrahim called the “gamesmanship” of the privilege process. The Federal Trade Commission (“FTC”), in prepared remarks delivered last October to the U.S. Senate Committee on the Judiciary Subcommittee on Antitrust, Competition Policy, and Consumer Rights, made similar sweeping remarks about the need to study ways to hasten the pace in which the FTC completes a merger investigation.

According to a recent survey, however, the results of these efforts have been mixed. During a rolling 12-month period ending in the second quarter of 2019, the average investigation, from announcement to completion, appears to have taken approximately 11.4 months. Moreover, while DOJ appears to be moving the process along faster, approximately 75 percent of the investigations led by the FTC during this surveyed time period lasted more than 16 months. Almost a third of all of these investigations (DOJ and FTC combined) have been in the health care and pharmaceutical industries.

The bottom line is that while the enforcers are making an effort to expedite the merger review process, clearly more needs to be done. Furthermore, parties to a transaction subject to a significant investigation should be prepared to wait as much as a year or more before the investigation is completed.

* * *

For additional information about the issues discussed above, or if you have any other antitrust concerns, please contact the Epstein Becker Green attorney who regularly handles your legal matters, or one of the authors of this Antitrust Byte:

E. John Steren
Member of the Firm
esteren@ebglaw.com
Patricia Wagner
General Counsel / Chief Privacy Officer
pwagner@ebglaw.com
Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.